Registration
SIDLEY AUSTIN LLP for KARYOPHARM THERAPEUTICS
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Rare disease policy, drug approval process
| Lobbyist | Covered position, as disclosed |
|---|---|
| ABIGAIL CARROLL New | Detailee to the Energy and Commerce Committee, U.S. House of Representatives |
| PATRICIA LOUISE DELOATCHE New | Health Policy Director, Sen. Orrin Hatch; Chief of Staff,Legislative Director, Legislative Assistant, Rep. MikeBilirakis |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.